U.S. Markets closed

Free Research Report as HCA Healthcare's Revenue Grew 8%; Adjusted EPS Surged 34%

Stock Monitor: SunLink Health Systems Post Earnings Reporting

LONDON, UK / ACCESSWIRE / May 22, 2018 / If you want access to our free earnings report on HCA Healthcare, Inc. (NYSE: HCA), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HCA. HCA Healthcare reported its first-quarter fiscal 2018 operating and financial results on May 01, 2018. The hospital operator outperformed top- and bottom-line expectations. Additionally, the Company provided guidance for the full year 2018. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for SunLink Health Systems, Inc. (NYSE AMER: SSY), which also belongs to the Healthcare sector as the Company HCA Healthcare. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=SSY

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, HCA Healthcare most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HCA

Earnings Highlights and Summary

HCA Healthcare's revenues in the first quarter 2018 increased 8% to $11.42 billion compared to $10.62 billion in Q1 2017. The Company's reported numbers exceeded analysts' estimates of $11.27 billion.

During Q1 2018, HCA Healthcare's adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) totaled $2.12 billion, up 5% compared to $2.01 billion in Q1 2017.

During Q1 2018, HCA Healthcare's same facility equivalent admissions and admissions increased 1.8% and 2.2% respectively, compared to the prior year's corresponding period. The Company's same facility emergency room visits increased 3.5% in the reported quarter.

For Q1 2018, HCA Healthcare's inpatient surgeries rose 0.3%, while outpatient surgeries declined 0.5%, on a same facility basis. The Company's same facility revenue per equivalent admission grew 3.9% in the reported quarter.

During Q1 2018, HCA Healthcare's salaries and benefits, supplies and other operating expenses totaled $9.314 billion, or 81.6% of revenues, compared to $8.628 billion, or 81.2% of revenues, in Q1 2017.

For Q1 2018, net income attributable to HCA Healthcare totaled $1.14 billion, or $3.18 per diluted share, compared to $659 million, or $1.74 per diluted share, in Q1 2017. The Company's reported quarter results include gains on sales of facilities of $405 million, or $0.85 per diluted share, primarily reflecting the sale of the Company's Oklahoma facilities. HCA Healthcare recognized a tax benefit of $92 million, or $0.26 per diluted share, in Q1 2018 compared to $67 million, or $0.18 per diluted share, in Q1 2017 related to employee equity award settlements.

On an adjusted basis, HCA Healthcare's reported net income totaled $2.33 per diluted share, up 34% compared to $1.74 per diluted share.

Balance Sheet and Cash Flow

As of March 31, 2018, HCA Healthcare's balance sheet reflected cash and cash equivalents of $1.09 billion, total debt of $33.29 billion, and total assets of $37.30 billion. During Q1 2018, the Company's capital expenditures totaled $694 million, excluding acquisitions.

For Q1 2018, HCA Healthcare's cash flows provided by operating activities totaled $1.30 billion compared to $1.28 billion in Q1 2017. As of March 31, 2018, the Company's leverage ratio as measured by total debt/adjusted EBITDA was 3.99x compared to 4.02x as of December 31, 2017.

During Q1 2018, HCA Healthcare repurchased 4.37 million shares of its common stock at a cost of $423 million. At March 31, 2018, the Company had $1.38 billion remaining under the existing $2.0 billion repurchase authorization. HCA Healthcare had 350.99 million shares outstanding as of March 31, 2018.

As of March 31, 2018, HCA Healthcare operated 178 hospitals and approximately 1,800 sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics in 20 states and the United Kingdom.

Dividend

HCA Healthcare announced that its Board of Directors declared a quarterly cash dividend of $0.35 per share on the Company's common stock. The dividend will be paid on June 29, 2018, to stockholders of record at the close of business on June 01, 2018.

Outlook

For full-year 2018, HCA Healthcare is forecasting revenue in the range of $45.0 million to $46.0 million. The Company is expecting earnings in the range of $8.50 to $9.00 per diluted share, and adjusted EBITDA in the band of $8.45 billion to $8.75 billion.

Stock Performance Snapshot

May 21, 2018 - At Monday's closing bell, HCA Healthcare's stock advanced 1.00%, ending the trading session at $103.86.

Volume traded for the day: 1.35 million shares.

Stock performance in the last month – up 6.58%; previous three-month period – up 2.83%; past twelve-month period – up 26.43%; and year-to-date – up 18.24%

After yesterday's close, HCA Healthcare's market cap was at $36.68 billion.

Price to Earnings (P/E) ratio was at 12.65.

The stock has a dividend yield of 1.35%.

The stock is part of the Healthcare sector, categorized under the Hospitals industry. This sector was flat at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors